We are developing the first bedside, blood based stroke test.
Using lateral flow technology, this test will empower healthcare providers to identify strokes more quickly, accurately and confidently.
This will reduce the vast diagnostic grey area that leads to morbidity and mortality in patients as a result of vague stroke symptoms or unclear time of onset.
What is it?
Our FASTER system is a Point of Care (PoC) test that offers rapid and accurate assistance in stroke diagnosis. Our proprietary technology is designed to help identify stroke and time of onset in less than 15 minutes.
Patent protected protein biomarker Glutathione-S-Transferase Pi (GSTP) is the foundation of our technology. With only a few drops of blood and the simple lateral flow device, medical providers can quickly asses GSTP levels and infer critical information about their patient’s condition.
